Amneal Pharmaceuticals, Inc. Class A Common Stock Cash Flow Conversion Efficiency
Amneal Pharmaceuticals, Inc. Class A Common Stock cash flow conversion efficiency. Based on the latest financial reports, Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a cash flow conversion efficiency ratio of 0.144x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($118.45 Million) by net assets ($819.93 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Amneal Pharmaceuticals, Inc. Class A Common Stock (2015–2024)
Cash flow conversion efficiency of Amneal Pharmaceuticals, Inc. Class A Common Stock from 2015 to 2024. This chart illustrates how Amneal Pharmaceuticals, Inc. Class A Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View AMRX stock price for real-time trading data and today's change.
Amneal Pharmaceuticals, Inc. Class A Common Stock Cash Flow Conversion Ratio Explained
Amneal Pharmaceuticals, Inc. Class A Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Amneal Pharmaceuticals, Inc. Class A Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amneal Pharmaceuticals, Inc. Class A Common Stock ranked by their cash flow conversion efficiency. Also see Amneal Pharmaceuticals, Inc. Class A Com stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ROCKWOOL International A/S
CO:ROCK-B
|
0.059x |
|
Olav Thon Eien
OL:OLT
|
0.000x |
|
Peyto Exploration&Development Corp
TO:PEY
|
0.074x |
|
China Coal Xinji Energy Co Ltd
SHG:601918
|
0.023x |
|
Aecc Aero Engine Control Co Ltd
SHE:000738
|
0.020x |
|
Heilongjiang Agriculture Co Ltd
SHG:600598
|
-0.195x |
|
Organon & Co
NYSE:OGN
|
0.106x |
|
Holmen AB (publ)
ST:HOLM-B
|
0.023x |
Annual Cash Flow Conversion Efficiency for Amneal Pharmaceuticals, Inc. Class A Common Stock (2015–2024)
The table below shows the annual cash flow conversion efficiency of Amneal Pharmaceuticals, Inc. Class A Common Stock from 2015 to 2024. Review Amneal Pharmaceuticals, Inc. Class A Com free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-44.54 Million | $295.10 Million | -6.626x | -138.37% |
| 2023-12-31 | $20.01 Million | $345.58 Million | 17.269x | +5442.32% |
| 2022-12-31 | $208.93 Million | $65.10 Million | 0.312x | -52.71% |
| 2021-12-31 | $366.97 Million | $241.82 Million | 0.659x | -40.03% |
| 2020-12-31 | $344.93 Million | $379.00 Million | 1.099x | +22248.41% |
| 2019-12-31 | $346.79 Million | $1.71 Million | 0.005x | -98.24% |
| 2018-12-31 | $896.36 Million | $250.23 Million | 0.279x | +144.77% |
| 2017-12-31 | $-375.58 Million | $234.19 Million | -0.624x | +4.65% |
| 2016-12-31 | $-175.94 Million | $115.06 Million | -0.654x | -16.52% |
| 2015-12-31 | $-186.87 Million | $104.88 Million | -0.561x | -- |
About Amneal Pharmaceuticals, Inc. Class A Common Stock
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate an… Read more